Structural analysis of CYP2C9 and CYP2C5 and an evaluation of commonly used molecular modeling techniques

Lovisa Afzelius1, Florian Raubacher, Anders Karlén

  • 1Department of Drug Metabolism and Pharmacokinetics and Bioanalytical Chemistry, AstraZeneca R&D, Mölndal, Sweden. Lovisa.afzelius@astrazeneca.com